CERS6 and metastatic malignant neoplasm in the lymph nodes: Through the analysis of the clinical characteristics of 126 gastric cancer patients, it can be concluded that the expression of CERS6-AS1 is not only related to lymph node metastasis, but also has a significant correlation with tumor-node-metastasis (TNM) stage (P < 0.001).